Brain metastases in colorectal cancer: prognostic factors and survival analysis

Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our cent...

Full description

Saved in:
Bibliographic Details
Published in:International journal of colorectal disease Vol. 33; no. 11; pp. 1517 - 1523
Main Authors: Del Carpio Huerta, Luis, Virgili Manrique, Anna Cristina, Szafranska, Justyna, Martin-Richard, Marta, Paez Lopez-Bravo, David, Sebio Garcia, Ana, Espinosa Mariscal, Iñigo, Gomila Pons, Paula, Andres Granyo, Marta, Barba Joaquin, Andres, Barnadas Molins, Agusti, Tobeña Puyal, Maria
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-11-2018
Springer
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Results Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p  = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p  = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p  = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0–1, respectively; HR = 3.7, p  = 0.015). RAS/BRAF status did not showed prognostic value. Conclusions Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
AbstractList PURPOSEColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM.PATIENTSWe retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated.RESULTSTwenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value.CONCLUSIONSTime to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Results Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p  = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p  = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p  = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0–1, respectively; HR = 3.7, p  = 0.015). RAS/BRAF status did not showed prognostic value. Conclusions Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
PurposeColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM.PatientsWe retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated.ResultsTwenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0–1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value.ConclusionsTime to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Results Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Conclusions Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients.
Audience Academic
Author Andres Granyo, Marta
Virgili Manrique, Anna Cristina
Barnadas Molins, Agusti
Martin-Richard, Marta
Del Carpio Huerta, Luis
Paez Lopez-Bravo, David
Espinosa Mariscal, Iñigo
Gomila Pons, Paula
Sebio Garcia, Ana
Szafranska, Justyna
Barba Joaquin, Andres
Tobeña Puyal, Maria
Author_xml – sequence: 1
  givenname: Luis
  orcidid: 0000-0001-9017-2460
  surname: Del Carpio Huerta
  fullname: Del Carpio Huerta, Luis
  email: Lcarpio@santpau.cat
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 2
  givenname: Anna Cristina
  surname: Virgili Manrique
  fullname: Virgili Manrique, Anna Cristina
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 3
  givenname: Justyna
  surname: Szafranska
  fullname: Szafranska, Justyna
  organization: Pathology Department, Santa Creu i Sant Pau Hospital
– sequence: 4
  givenname: Marta
  surname: Martin-Richard
  fullname: Martin-Richard, Marta
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 5
  givenname: David
  surname: Paez Lopez-Bravo
  fullname: Paez Lopez-Bravo, David
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 6
  givenname: Ana
  surname: Sebio Garcia
  fullname: Sebio Garcia, Ana
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 7
  givenname: Iñigo
  surname: Espinosa Mariscal
  fullname: Espinosa Mariscal, Iñigo
  organization: Pathology Department, Santa Creu i Sant Pau Hospital
– sequence: 8
  givenname: Paula
  surname: Gomila Pons
  fullname: Gomila Pons, Paula
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 9
  givenname: Marta
  surname: Andres Granyo
  fullname: Andres Granyo, Marta
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 10
  givenname: Andres
  surname: Barba Joaquin
  fullname: Barba Joaquin, Andres
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 11
  givenname: Agusti
  surname: Barnadas Molins
  fullname: Barnadas Molins, Agusti
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
– sequence: 12
  givenname: Maria
  surname: Tobeña Puyal
  fullname: Tobeña Puyal, Maria
  email: Mtobena@santpau.cat
  organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29943356$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1LHTEYhYNY6tX2B7iRgW66GZvvj-6sVC0Ibtp1yM28uURmEpvMCP775nq1orQkEN7kOYcTziHaTzkBQscEnxKM1ZeKMdO8x0T3jGDVyz20IpzRnlBJ99EKE2V6YoQ-QIe13uI2S8XfowNqDGdMyBW6-VZcTN0Es6ttQ-3a5POYC_jZjZ13yUP52t2VvEm5ztF3wfk5l9q5NHR1KffxvnEuufGhxvoBvQturPDx6TxCvy6-_zy_6q9vLn-cn133njMz93qtCGOGCoaVGwRfCyaFZACMBd3CYwhKCjNwIumaMu314JwkAcAICI06Qp93vi3Y7wXqbKdYPYyjS5CXaikWRnCjOGnopzfobV5Ky_tIac05VviF2rgRbEwhz8X5rak9U4RzrRnfUqf_oNoaYIq-tRNiu38lIDuBL7nWAsHelTi58mAJttsS7a5E20q02xKtbJqTp8DLeoLhr-K5tQbQHVDbU9pAefnR_13_ADr-plU
CitedBy_id crossref_primary_10_3862_jcoloproctology_75_44
crossref_primary_10_5582_bst_2019_01044
crossref_primary_10_1007_s00384_019_03306_1
crossref_primary_10_1016_j_semcancer_2019_10_010
crossref_primary_10_2147_CMAR_S320179
crossref_primary_10_3390_diagnostics12071586
crossref_primary_10_1186_s40792_022_01407_8
crossref_primary_10_1259_bjr_20200951
crossref_primary_10_3389_fmed_2022_768896
crossref_primary_10_3390_cancers13040900
Cites_doi 10.1097/01.dcr.0000436998.30504.98
10.1007/s11060-010-0214-9
10.1002/jso.23055
10.1093/annonc/mdu275
10.7314/APJCP.2016.17.4.2545
10.1007/s00384-013-1781-y
10.1007/s12094-015-1341-8
10.1159/000478661
10.1016/j.ijrobp.2008.12.031
10.3322/caac.21387
10.1111/ans.14107
10.1007/s10151-017-1707-8
10.1038/s41598-017-08413-z
10.1001/jamaoncol.2016.4227
10.1007/s12094-015-1340-9
10.1002/cncr.23531
10.1016/j.canrad.2013.12.003
10.3748/wjg.v21.i41.11767
10.1002/cncr.29196
10.1016/j.ejca.2017.07.016
10.1016/j.clcc.2015.05.009
10.21037/jgo.2016.12.11
10.2217/fon-2016-0196
10.1007/s12032-014-0152-z
10.1016/j.clcc.2014.09.008
10.4161/cbt.28550
10.1080/0284186X.2017.1290272
10.1186/1756-9966-30-10
10.1007/s11845-015-1272-y
10.3816/CCC.2009.n.016
ContentType Journal Article
Copyright Springer-Verlag GmbH Germany, part of Springer Nature 2018
COPYRIGHT 2018 Springer
International Journal of Colorectal Disease is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2018
– notice: COPYRIGHT 2018 Springer
– notice: International Journal of Colorectal Disease is a copyright of Springer, (2018). All Rights Reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s00384-018-3107-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

ProQuest One Academic Eastern Edition

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1262
EndPage 1523
ExternalDocumentID A714488340
10_1007_s00384_018_3107_6
29943356
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFDYV
AFEXP
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z7X
Z82
Z87
Z8O
Z8P
Z8Q
Z8V
Z91
ZMTXR
ZOVNA
~EX
~KM
AAEOY
AAKKN
AAYZH
ABAKF
ABEEZ
ACACY
ACULB
ACZOJ
AEFQL
AFBBN
AFGXO
AGQEE
AGRTI
AJOOF
ALIPV
C24
C6C
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7T5
7XB
8FK
H94
K9.
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c439t-8b7133925307ad54b536563ee33f82620ef7659d4162b238c8daa61fee95efe33
IEDL.DBID AEJHL
ISSN 0179-1958
IngestDate Sat Oct 26 00:38:02 EDT 2024
Wed Nov 06 08:31:09 EST 2024
Tue Nov 19 21:17:00 EST 2024
Tue Nov 12 22:50:58 EST 2024
Thu Nov 21 21:28:34 EST 2024
Wed Oct 16 00:50:37 EDT 2024
Sat Dec 16 12:00:36 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Brain metastases
Colorectal cancer location
Whole brain radiotherapy
Surgery
Colorectal cancer
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-8b7133925307ad54b536563ee33f82620ef7659d4162b238c8daa61fee95efe33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9017-2460
PMID 29943356
PQID 2058844070
PQPubID 31377
PageCount 7
ParticipantIDs proquest_miscellaneous_2059549741
proquest_journals_2058844070
gale_infotracmisc_A714488340
gale_infotracacademiconefile_A714488340
crossref_primary_10_1007_s00384_018_3107_6
pubmed_primary_29943356
springer_journals_10_1007_s00384_018_3107_6
PublicationCentury 2000
PublicationDate 2018-11-01
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: New York
PublicationSubtitle Clinical and Molecular Gastroenterology and Surgery
PublicationTitle International journal of colorectal disease
PublicationTitleAbbrev Int J Colorectal Dis
PublicationTitleAlternate Int J Colorectal Dis
PublicationYear 2018
Publisher Springer Berlin Heidelberg
Springer
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer
– name: Springer Nature B.V
References Fausto Petrelli, Gianluca Tomasello, Karen Borgonovo, Michele Ghidini, Luca Turati, PierpaoloDallera, Rodolfo Passalacqua, Giovanni Sgroi, Sandro Barni (CR20) 2016; 3
Lin, Zhao, Ge, Wang, Chen, Liu, Jia, Liu, Liu, Xu (CR22) 2016; 18
Vatandoust, Price, Karapetis (CR31) 2015; 21
Feuvret, Vinchon, Martin, Lamproglou, Halley, Calugaru, Chea, Valéry, Simon, Mazeron (CR30) 2014; 18
Christensen, Palshof, Larsen, Høgdall, Poulsen, Pfeiffer, Jensen, Yilmaz, Christensen, Nielsen (CR10) 2017; 56
Hussain, Waqas, Hassan (CR19) 2016; 17
Siegel, Miller, Jemal (CR1) 2017; 67
Kased, Binder, McDermott (CR29) 2009; 75
Kruser, Chao, Elson, Barnett, Vogelbaum, Angelov, Weil, Pelley, Suh (CR4) 2008; 113
Suzuki, Yamaguchi, Matsumoto, Nakano, Honda, Shinoura, Karasawa, Takahashi (CR8) 2014; 57
Nozawa, Ishihara, Kawai, Sasaki, Murono, Otani, Nishikawa, Tanaka, Kiyomatsu, Hata, Watanabe (CR24) 2017; 93
Fountzilas, Chang, Hernandez, Michalek, Crownover, Floyd, Mahalingam (CR5) 2017; 8
Tanriverdi, Kaytan-Saglam, Ulger, Bayoglu, Turker, Ozturk-Topcu, Cokmert, Turhal, Oktay, Karabulut, Kilic, Kucukzeybek, Oksuzoglu, Meydan, Kaya, Akman, Ibis, Saynak, Sen, Uysal-Sonmez, Pilancı, Demir, Saglam, Kocar, Menekse, Goksel, Yapar-Taskoylu, Yaren, Uyeturk, Avci, Denizli, Ilis-Temiz (CR3) 2014; 31
Gaspar, Scott, Rotman (CR13) 1997; 37
Tong, Lung, Sin, Law, Kang, Chan, Ma, Mak, Ng, To (CR15) 2014; 15
Yaeger, Cowell, Chou, Gewirtz, Borsu, Vakiani, Solit, Rosen, Capanu, Ladanyi, Kemeny (CR12) 2015; 121
Gao, Yu, Gong, Liu, Xu, Hao, Liu, Liu, Bai, Zhang (CR17) 2017; 7
Fabi, Felici, Metro, Mirri, Bria, Telera, Moscetti, Russillo, Lanzetta, Mansueto, Pace, Maschio, Vidiri, Sperduti, Cognetti, Carapella (CR2) 2011; 30
Michl, Thurmaier, Schubert-Fritschle, Wiedemann, Laubender, Nüssler, Ruppert, Kleeff, Schepp, Reuter, Löhe, Karthaus, Neumann, Kirchner, Engel, Heinemann (CR9) 2015; 14
Missiaglia, Jacobs, D’Ario (CR16) 2014; 25
Mege, Sans, Ouaissi, Iannelli, Sielezneff (CR28) 2017; 88
Stintzing, Tejpar, Gibbs, Thiebach (CR18) 2017; 84
Nieder, Hintz, Grosu (CR27) 2016; 18
Aprile, Casagrande, De Maglio (CR25) 2017; 13
Silva, Iskandarani, Hotouras, Murphy, Bhan, Adada, Wexner (CR14) 2017; 21
Tevlin, Larkin, Hyland, O’Connell, Winter (CR7) 2015; 184
Tokoro, Okuno, Hida, Ueda, Yoshifuji, Daito, Sugiura (CR11) 2014; 13
Magni, Santoro, Ravenda, Leonardi, Bonomo, Monfardini, Nolè, Zampino (CR21) 2014; 29
Mongan, Fadul, Cole, Zaki, Suriawinata, Ripple, Tosteson, Pipas (CR23) 2009; 8
Noura, Ohue, Shingai, Fujiwara, Imada, Sueda, Yamada, Fujiwara, Ohigashi, Yano, Ishikawa (CR6) 2012; 106
Jung, Ahn, Chang, Suh, Hong, Roh, Shin, Rha (CR26) 2011; 101
C Nieder (3107_CR27) 2016; 18
E Missiaglia (3107_CR16) 2014; 25
E Magni (3107_CR21) 2014; 29
M Jung (3107_CR26) 2011; 101
XH Gao (3107_CR17) 2017; 7
R Tevlin (3107_CR7) 2015; 184
N Kased (3107_CR29) 2009; 75
Yozo Suzuki (3107_CR8) 2014; 57
H Nozawa (3107_CR24) 2017; 93
S Vatandoust (3107_CR31) 2015; 21
MD Fausto Petrelli (3107_CR20) 2016; 3
L Lin (3107_CR22) 2016; 18
L Feuvret (3107_CR30) 2014; 18
A Fabi (3107_CR2) 2011; 30
G Aprile (3107_CR25) 2017; 13
M Michl (3107_CR9) 2015; 14
R Yaeger (3107_CR12) 2015; 121
O Tanriverdi (3107_CR3) 2014; 31
RL Siegel (3107_CR1) 2017; 67
TD Christensen (3107_CR10) 2017; 56
JP Mongan (3107_CR23) 2009; 8
T Tokoro (3107_CR11) 2014; 13
S Noura (3107_CR6) 2012; 106
D Mege (3107_CR28) 2017; 88
TJ Kruser (3107_CR4) 2008; 113
S Stintzing (3107_CR18) 2017; 84
C Fountzilas (3107_CR5) 2017; 8
L Gaspar (3107_CR13) 1997; 37
JHM Tong (3107_CR15) 2014; 15
M Hussain (3107_CR19) 2016; 17
IL Silva (3107_CR14) 2017; 21
References_xml – volume: 57
  start-page: 56
  issue: 1
  year: 2014
  end-page: 63
  ident: CR8
  article-title: Prognostic Factors and Treatment Effects in Patients With Curatively Resected Brain Metastasis From Colorectal Cancer
  publication-title: Diseases of the Colon & Rectum
  doi: 10.1097/01.dcr.0000436998.30504.98
  contributor:
    fullname: Takahashi
– volume: 101
  start-page: 49
  year: 2011
  end-page: 55
  ident: CR26
  article-title: Brain metastases from colorectal carcinoma: prognostic factors and outcome
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-010-0214-9
  contributor:
    fullname: Rha
– volume: 106
  start-page: 144
  year: 2012
  end-page: 148
  ident: CR6
  article-title: Brain metastasis from colorectal cancer: prognostic factors and survival
  publication-title: J Surg Oncol
  doi: 10.1002/jso.23055
  contributor:
    fullname: Ishikawa
– volume: 25
  start-page: 1995
  year: 2014
  end-page: 2001
  ident: CR16
  article-title: Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdu275
  contributor:
    fullname: D’Ario
– volume: 17
  start-page: 2545
  year: 2016
  end-page: 2548
  ident: CR19
  article-title: Right-sided and left-sided colon cancers are two distinct disease entities: an analysis of 200 cases in Pakistan
  publication-title: Asian Pacific J Cancer Prev
  doi: 10.7314/APJCP.2016.17.4.2545
  contributor:
    fullname: Hassan
– volume: 29
  start-page: 201
  year: 2014
  end-page: 208
  ident: CR21
  article-title: Brain metastases from colorectal cancer: main clinical factors conditioning outcome
  publication-title: Int J Color Dis
  doi: 10.1007/s00384-013-1781-y
  contributor:
    fullname: Zampino
– volume: 18
  start-page: 93
  year: 2016
  end-page: 98
  ident: CR22
  article-title: Patients with brain metastases derived from gastrointestinal cancer: clinical characteristics and prognostic factors
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-015-1341-8
  contributor:
    fullname: Xu
– volume: 93
  start-page: 309
  year: 2017
  end-page: 314
  ident: CR24
  article-title: Brain metastasis from colorectal cancer: predictors and treatment outcomes
  publication-title: Oncology
  doi: 10.1159/000478661
  contributor:
    fullname: Watanabe
– volume: 75
  start-page: 1132
  year: 2009
  end-page: 1140
  ident: CR29
  article-title: Gamma Knife radiosurgery for brain metastases from primary breast cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.12.031
  contributor:
    fullname: McDermott
– volume: 67
  start-page: 7
  year: 2017
  end-page: 30
  ident: CR1
  article-title: Cancer statistics, 2017
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21387
  contributor:
    fullname: Jemal
– volume: 88
  start-page: 140
  year: 2017
  end-page: 145
  ident: CR28
  article-title: Brain metastases from colorectal cancer: characteristics and management
  publication-title: ANZ J Surg
  doi: 10.1111/ans.14107
  contributor:
    fullname: Sielezneff
– volume: 21
  start-page: 847
  year: 2017
  end-page: 852
  ident: CR14
  article-title: A systematic review to assess the management of patients with cerebral metastases secondary to colorectal cancer
  publication-title: Tech Coloproctol
  doi: 10.1007/s10151-017-1707-8
  contributor:
    fullname: Wexner
– volume: 7
  year: 2017
  ident: CR17
  article-title: Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-08413-z
  contributor:
    fullname: Zhang
– volume: 3
  start-page: 1
  year: 2016
  end-page: 9
  ident: CR20
  article-title: Prognostic survival associated with left-sided vs right-sided Colon Cancer a systematic review and meta-analysis
  publication-title: Jama Oncol
  doi: 10.1001/jamaoncol.2016.4227
  contributor:
    fullname: Sandro Barni
– volume: 18
  start-page: 88
  year: 2016
  end-page: 92
  ident: CR27
  article-title: Colorectal cancer metastatic to the brain: analysis of prognostic factors and impact of KRAS mutations on presentation and outcome
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-015-1340-9
  contributor:
    fullname: Grosu
– volume: 113
  start-page: 158
  year: 2008
  end-page: 165
  ident: CR4
  article-title: Multidisciplinary management of colorectal brain metastases: a retrospective study
  publication-title: Cancer
  doi: 10.1002/cncr.23531
  contributor:
    fullname: Suh
– volume: 18
  start-page: 97
  year: 2014
  end-page: 106
  ident: CR30
  article-title: Stereotactic radiotherapy for large solitary brain metastases
  publication-title: Cancer/Radiotherapie
  doi: 10.1016/j.canrad.2013.12.003
  contributor:
    fullname: Mazeron
– volume: 21
  start-page: 11767
  year: 2015
  end-page: 11776
  ident: CR31
  article-title: Colorectal cancer: metastases to a single organ
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i41.11767
  contributor:
    fullname: Karapetis
– volume: 121
  start-page: 1195
  year: 2015
  end-page: 1203
  ident: CR12
  article-title: RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer
  publication-title: Cancer
  doi: 10.1002/cncr.29196
  contributor:
    fullname: Kemeny
– volume: 84
  start-page: 69
  year: 2017
  end-page: 80
  ident: CR18
  article-title: Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2017.07.016
  contributor:
    fullname: Thiebach
– volume: 14
  start-page: 281
  year: 2015
  end-page: 290
  ident: CR9
  article-title: Brain metastasis in colorectal cancer patients: survival and analysis of prognostic factors
  publication-title: Clin Colorectal Cancer
  doi: 10.1016/j.clcc.2015.05.009
  contributor:
    fullname: Heinemann
– volume: 37
  start-page: 745
  year: 1997
  end-page: 751
  ident: CR13
  article-title: Analysis ( Rpa ) of prognostic factors therapy oncology group ( Rtog ) trials
  publication-title: Radiat Oncol
  contributor:
    fullname: Rotman
– volume: 8
  start-page: 55
  year: 2017
  end-page: 63
  ident: CR5
  article-title: Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience
  publication-title: J Gastrointest Oncol
  doi: 10.21037/jgo.2016.12.11
  contributor:
    fullname: Mahalingam
– volume: 13
  start-page: 135
  issue: 2
  year: 2017
  end-page: 144
  ident: CR25
  article-title: Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors
  publication-title: Future Oncol
  doi: 10.2217/fon-2016-0196
  contributor:
    fullname: De Maglio
– volume: 31
  year: 2014
  ident: CR3
  article-title: The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG)
  publication-title: Med Oncol
  doi: 10.1007/s12032-014-0152-z
  contributor:
    fullname: Ilis-Temiz
– volume: 13
  start-page: 226
  year: 2014
  end-page: 231
  ident: CR11
  article-title: Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases
  publication-title: Clin Color Cancer
  doi: 10.1016/j.clcc.2014.09.008
  contributor:
    fullname: Sugiura
– volume: 15
  start-page: 768
  year: 2014
  end-page: 776
  ident: CR15
  article-title: Characterization of rare transforming KRAS mutations in sporadic colorectal cancer
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.28550
  contributor:
    fullname: To
– volume: 56
  start-page: 639
  year: 2017
  end-page: 645
  ident: CR10
  article-title: Risk factors for brain metastases in patients with metastatic colorectal cancer
  publication-title: Acta Oncol
  doi: 10.1080/0284186X.2017.1290272
  contributor:
    fullname: Nielsen
– volume: 30
  start-page: 10
  year: 2011
  ident: CR2
  article-title: Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-30-10
  contributor:
    fullname: Carapella
– volume: 184
  start-page: 673
  year: 2015
  end-page: 675
  ident: CR7
  article-title: Brain metastasis from colorectal carcinoma: a single cancer centre experience
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-015-1272-y
  contributor:
    fullname: Winter
– volume: 8
  start-page: 100
  year: 2009
  end-page: 105
  ident: CR23
  article-title: Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines
  publication-title: Clin Color Cancer
  doi: 10.3816/CCC.2009.n.016
  contributor:
    fullname: Pipas
– volume: 21
  start-page: 847
  year: 2017
  ident: 3107_CR14
  publication-title: Tech Coloproctol
  doi: 10.1007/s10151-017-1707-8
  contributor:
    fullname: IL Silva
– volume: 67
  start-page: 7
  year: 2017
  ident: 3107_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21387
  contributor:
    fullname: RL Siegel
– volume: 3
  start-page: 1
  year: 2016
  ident: 3107_CR20
  publication-title: Jama Oncol
  doi: 10.1001/jamaoncol.2016.4227
  contributor:
    fullname: MD Fausto Petrelli
– volume: 18
  start-page: 88
  year: 2016
  ident: 3107_CR27
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-015-1340-9
  contributor:
    fullname: C Nieder
– volume: 8
  start-page: 100
  year: 2009
  ident: 3107_CR23
  publication-title: Clin Color Cancer
  doi: 10.3816/CCC.2009.n.016
  contributor:
    fullname: JP Mongan
– volume: 106
  start-page: 144
  year: 2012
  ident: 3107_CR6
  publication-title: J Surg Oncol
  doi: 10.1002/jso.23055
  contributor:
    fullname: S Noura
– volume: 84
  start-page: 69
  year: 2017
  ident: 3107_CR18
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2017.07.016
  contributor:
    fullname: S Stintzing
– volume: 121
  start-page: 1195
  year: 2015
  ident: 3107_CR12
  publication-title: Cancer
  doi: 10.1002/cncr.29196
  contributor:
    fullname: R Yaeger
– volume: 88
  start-page: 140
  year: 2017
  ident: 3107_CR28
  publication-title: ANZ J Surg
  doi: 10.1111/ans.14107
  contributor:
    fullname: D Mege
– volume: 14
  start-page: 281
  year: 2015
  ident: 3107_CR9
  publication-title: Clin Colorectal Cancer
  doi: 10.1016/j.clcc.2015.05.009
  contributor:
    fullname: M Michl
– volume: 29
  start-page: 201
  year: 2014
  ident: 3107_CR21
  publication-title: Int J Color Dis
  doi: 10.1007/s00384-013-1781-y
  contributor:
    fullname: E Magni
– volume: 184
  start-page: 673
  year: 2015
  ident: 3107_CR7
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-015-1272-y
  contributor:
    fullname: R Tevlin
– volume: 17
  start-page: 2545
  year: 2016
  ident: 3107_CR19
  publication-title: Asian Pacific J Cancer Prev
  doi: 10.7314/APJCP.2016.17.4.2545
  contributor:
    fullname: M Hussain
– volume: 37
  start-page: 745
  year: 1997
  ident: 3107_CR13
  publication-title: Radiat Oncol
  contributor:
    fullname: L Gaspar
– volume: 25
  start-page: 1995
  year: 2014
  ident: 3107_CR16
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdu275
  contributor:
    fullname: E Missiaglia
– volume: 56
  start-page: 639
  year: 2017
  ident: 3107_CR10
  publication-title: Acta Oncol
  doi: 10.1080/0284186X.2017.1290272
  contributor:
    fullname: TD Christensen
– volume: 31
  year: 2014
  ident: 3107_CR3
  publication-title: Med Oncol
  doi: 10.1007/s12032-014-0152-z
  contributor:
    fullname: O Tanriverdi
– volume: 13
  start-page: 226
  year: 2014
  ident: 3107_CR11
  publication-title: Clin Color Cancer
  doi: 10.1016/j.clcc.2014.09.008
  contributor:
    fullname: T Tokoro
– volume: 15
  start-page: 768
  year: 2014
  ident: 3107_CR15
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.28550
  contributor:
    fullname: JHM Tong
– volume: 7
  year: 2017
  ident: 3107_CR17
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-08413-z
  contributor:
    fullname: XH Gao
– volume: 18
  start-page: 97
  year: 2014
  ident: 3107_CR30
  publication-title: Cancer/Radiotherapie
  doi: 10.1016/j.canrad.2013.12.003
  contributor:
    fullname: L Feuvret
– volume: 93
  start-page: 309
  year: 2017
  ident: 3107_CR24
  publication-title: Oncology
  doi: 10.1159/000478661
  contributor:
    fullname: H Nozawa
– volume: 30
  start-page: 10
  year: 2011
  ident: 3107_CR2
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-30-10
  contributor:
    fullname: A Fabi
– volume: 57
  start-page: 56
  issue: 1
  year: 2014
  ident: 3107_CR8
  publication-title: Diseases of the Colon & Rectum
  doi: 10.1097/01.dcr.0000436998.30504.98
  contributor:
    fullname: Yozo Suzuki
– volume: 75
  start-page: 1132
  year: 2009
  ident: 3107_CR29
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.12.031
  contributor:
    fullname: N Kased
– volume: 8
  start-page: 55
  year: 2017
  ident: 3107_CR5
  publication-title: J Gastrointest Oncol
  doi: 10.21037/jgo.2016.12.11
  contributor:
    fullname: C Fountzilas
– volume: 113
  start-page: 158
  year: 2008
  ident: 3107_CR4
  publication-title: Cancer
  doi: 10.1002/cncr.23531
  contributor:
    fullname: TJ Kruser
– volume: 101
  start-page: 49
  year: 2011
  ident: 3107_CR26
  publication-title: J Neuro-Oncol
  doi: 10.1007/s11060-010-0214-9
  contributor:
    fullname: M Jung
– volume: 18
  start-page: 93
  year: 2016
  ident: 3107_CR22
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-015-1341-8
  contributor:
    fullname: L Lin
– volume: 21
  start-page: 11767
  year: 2015
  ident: 3107_CR31
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i41.11767
  contributor:
    fullname: S Vatandoust
– volume: 13
  start-page: 135
  issue: 2
  year: 2017
  ident: 3107_CR25
  publication-title: Future Oncol
  doi: 10.2217/fon-2016-0196
  contributor:
    fullname: G Aprile
SSID ssj0017674
Score 2.32439
Snippet Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment...
Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and...
Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment...
PurposeColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities...
PURPOSEColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities...
SourceID proquest
gale
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1517
SubjectTerms Adult
Aged
Aged, 80 and over
Analysis
Brain cancer
Brain Neoplasms - secondary
Care and treatment
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - pathology
Diagnosis
Female
Gastroenterology
Hepatology
Homeopathy
Humans
Internal Medicine
Male
Materia medica and therapeutics
Medical prognosis
Medicine
Medicine & Public Health
Metastases
Metastasis
Middle Aged
Original Article
Patient outcomes
Patients
Proctology
Prognosis
Radiation therapy
Surgery
Survival
Survival Analysis
Therapeutics
Time Factors
Young Adult
Title Brain metastases in colorectal cancer: prognostic factors and survival analysis
URI https://link.springer.com/article/10.1007/s00384-018-3107-6
https://www.ncbi.nlm.nih.gov/pubmed/29943356
https://www.proquest.com/docview/2058844070
https://search.proquest.com/docview/2059549741
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgkxAX3o_BQEVCQgIVlaZZU24DNk2IxwGQuEVpHhdEh9bt_2N3bWETHOAY5dE0tmM7Tj4DHAcpcoYJja-Vi3z0NwKUOZ34TDjjHDcsNkXqhKf44VXc9AgmJ6yPLrK38yoiWWzU9Vs3imHRhQk6zgtiv7MITVQ9HHm72e3dDu7q2AHB0xQXF-PEJyiVKpb50yAz2mh-T_6mlOaipIXy6a_-Z9prsFKaml53yhvrsGCzDVi6L4Ppm_B4RekhvHc7Vmgi5jb3sEQg1rQJYkdNDDG69OgKVzYkPGevzM7jqcx4-QR3GeRTLExxTbbgpd97vh74ZX4FX6MZMvZFSh5qEnKUc2V4lHKG1h2zljEnCKjeurjDE4M2W5iiatfCKNW5cNYm3DpstQ2NbJjZXfCcQ0NQGMu5CKNUo9eFpOYanZFUiUSrFpxW6yw_pjAasgZMLpZI4hJJWiLZacEJUUKSiI1HSqvypQB-isCqZDdGL1AIFgUtaM-0RNHQs9UVLWUpmrkMA3qbi34sVh_V1dSTrptldjgp2lD4E62tFuxMeaCeNurviDGOszyrKP41-K__tPen1vuwHBLLFG8e29AYjyb2ABZzMzksuf0TFUv2Vg
link.rule.ids 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153
linkProvider Springer Nature
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZT8MwDLZgSMAL9zHOIiEhgSqVpllT3sYlEDAeGBI8RWmONzq0bv8fuxcMwQM8RjmaOnZsx84XgMMgRc4wofG1cpGP_kaAMqcTnwlnnOOGxaZ4OuEp7r2IyyuCyWH1XZgi270OSRY7dXPZjYJYlDFB53lB7HemYYbAzsMWzHRfXl8vm-AB4dMUmYtx4hOWSh3M_GmQCXX0fVP-opW-hUkL7XO9-K95L8FCZWx63ZI7lmHKZisw-1CF01fh8ZweiPDe7EihkZjb3MMSwVjTNogdNbHE8MyjJK5sQIjOXvU-j6cy4-Vj3GeQU7FQIpuswfP1Vf_ixq9eWPA1GiIjX6TkoyYhR0lXhkcpZ2jfMWsZc4Kg6q2LOzwxaLWFKSp3LYxSnVNnbcKtw1br0MoGmd0Ezzk0BYWxnIswSjX6XbjYXKM7kiqRaNWG45rQ8r0E0pANZHJBIokkkkQi2WnDES2FJCEbDZVW1V0B_BTBVclujH6gECwK2rAz0RKFQ09W14spK-HMZRjQ7Vz0ZLH6oKmmnpRwltnBuGhDAVC0t9qwUTJBM23U4BFjHGd5Uq_45-C__tPWn1rvw9xN_-Fe3t_27rZhvjxRpoOfHWiNhmO7C9O5Ge9VrP8BQmP6hQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8RADA66gvjifaxnBUFQyta2s536IuuxKp6ggm_DdI43u7Lt_n-TXrqiD-JjmaNzJJNkknwDsOclSBna166SNnTR3vCQ51TsBtxqa5kOIl08nfAU3b_y8wuCyTmpc2GKaPfaJVnmNBBKU5p33rXtNIlv5NCi6Am62_MitzsJU3QrFrZgqnf9fNlvHAmEVVNEMUaxS7gqtWPzp07GRNP3A_qLhPrmMi0kUX_u33OYh9lKCXV6JdUswIRJF2H6rnKzL8HDKT0c4byZXKLymJnMwS-Ct6bjERsqIpXhsUPBXemAkJ6d6t0eR6bayUZ4_iAF40eJeLIML_2L57Mrt3p5wVWooOQuT8h2jX2GJ4DULExYgHpfYEwQWE4Q9sZGXRZr1Ob8BIW-4lrK7pE1JmbGYq0VaKWD1KyBYy2qiFwbxrgfJgrtMSQCptBMSSSPlWzDQb3o4r0E2BANlHKxRAKXSNASiW4b9mlbBDFfPpRKVjkE-CuCsRK9CO1DjoTgtWFzrCYyjRovrjdWVEybCd-jrF20cLF4tymmlhSIlprBqKhDjlHUw9qwWhJEM2yU7GEQMBzlYb37n53_Oqf1P9XegenH8764vb6_2YAZn6inSIzchFY-HJktmMz0aLvigg8SzQMu
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Brain+metastases+in+colorectal+cancer%3A+prognostic+factors+and+survival+analysis&rft.jtitle=International+journal+of+colorectal+disease&rft.au=Del+Carpio+Huerta%2C+Luis&rft.au=Virgili+Manrique%2C+Anna+Cristina&rft.au=Szafranska%2C+Justyna&rft.au=Martin-Richard%2C+Marta&rft.date=2018-11-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0179-1958&rft.eissn=1432-1262&rft.volume=33&rft.issue=11&rft.spage=1517&rft.epage=1523&rft_id=info:doi/10.1007%2Fs00384-018-3107-6&rft.externalDocID=10_1007_s00384_018_3107_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-1958&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-1958&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-1958&client=summon